Catalyst OrthoScience closed $15 million in equity and debt financing. This latest round strengthens Catalyst’s balance sheet and positions the company to advance its commercial and clinical programs.
With expanding surgeon adoption and growing enthusiasm for its differentiated portfolio — including the recently launched Catalyst Fracture Shoulder System — Catalyst continues to pursue its mission to simplify complex procedures.
Backed by a strong investor base and a leadership team with a record of disciplined growth, Catalyst is well-positioned to continue expanding its footprint across hospital and ambulatory surgery center markets.
Catalyst OrthoScience closed $15 million in equity and debt financing. This latest round strengthens Catalyst’s balance sheet and positions the company to advance its commercial and clinical programs.
With expanding surgeon adoption and growing enthusiasm for its differentiated portfolio — including the recently launched Catalyst Fracture...
Catalyst OrthoScience closed $15 million in equity and debt financing. This latest round strengthens Catalyst’s balance sheet and positions the company to advance its commercial and clinical programs.
With expanding surgeon adoption and growing enthusiasm for its differentiated portfolio — including the recently launched Catalyst Fracture Shoulder System — Catalyst continues to pursue its mission to simplify complex procedures.
Backed by a strong investor base and a leadership team with a record of disciplined growth, Catalyst is well-positioned to continue expanding its footprint across hospital and ambulatory surgery center markets.
Copy to clipboard 
